Skip to main content
. 2021 Dec 19;13(12):2196. doi: 10.3390/pharmaceutics13122196
API active pharmaceutical ingredient
BCA bicinchoninic acid assay
cATMP combined advanced therapy medicinal product
CHUV centre hospitalier universitaire vaudois
CMV cytomegalovirus
Da Daltons
DMEM Dulbecco’s modified Eagle medium
DMSO dimethyl sulfoxide
EBV Epstein-Barr virus
EDTA ethylenediaminetetraacetic acid
FBS fetal bovine serum
GAG glycosaminoglycan
GMP good manufacturing practices
GO gene ontology
HA hyaluronic acid
HBV hepatitis B virus
HCV hepatitis C virus
HIV human immunodeficiency virus
H2O2 hydrogen peroxide
HSV herpes simplex virus
HTLV human T-cell lymphotropic virus
LVE linear viscoelastic region
MCB master cell bank
MD medical device
MW molecular weight
Pa Pascals
Pa·s Pascal seconds
PBS phosphate-buffered saline
PCB parental cell bank
PDT population doubling time
PDV population doubling value
Ph. Eur. European pharmacopoeia
PRP platelet-rich plasma
QC quality control
ROS reactive oxygen species
TEAC Trolox equivalent antioxidant capacity
TrSt standardized transplant product
USA United States of America
UV ultraviolet
WCB working cell bank